Bisphosphonate 休薬期間が抜歯窩治癒過程に及ぼす影響についての実験的研究

The use of bisphosphonate (BP) after dental extraction has been reported to cause bisphosphonate-related osteonecrosis of the jaw (BRONJ). Avoidance of oral BP is recommended; however, no guidelines exist for intravenous BP. Therefore, we evaluated the influence of intravenous BP drug holiday (BPdh)...

Full description

Saved in:
Bibliographic Details
Published in日本口腔外科学会雑誌 Vol. 60; no. 11; pp. 596 - 608
Main Authors 渡邉, 竜太, 細原, 政俊, 式守, 道夫, 江㞍, 貞一, 村木, 智則, 伊藤, 友里, 笠井, 唯克, 厚地, 功誠
Format Journal Article
LanguageJapanese
Published 社団法人 日本口腔外科学会 20.11.2014
Subjects
Online AccessGet full text
ISSN0021-5163
2186-1579
DOI10.5794/jjoms.60.596

Cover

More Information
Summary:The use of bisphosphonate (BP) after dental extraction has been reported to cause bisphosphonate-related osteonecrosis of the jaw (BRONJ). Avoidance of oral BP is recommended; however, no guidelines exist for intravenous BP. Therefore, we evaluated the influence of intravenous BP drug holiday (BPdh) on post-extraction healing. Japanese white rabbits were used. In the sham group, saline was administered intravenously, and the mandibular premolar teeth were extracted; then, the mandible was collected 2-10 weeks after teeth extraction. In the BPdh group, zoledronate was administered intravenously. After 0, 1, 3, and 6 weeks of BPdh, the teeth were extracted. The jaws were collected 6 weeks after the tooth extractions. The healing status of the extraction socket was assessed. The cancellous bone volume (BV/ TV), trabecular separation (Tb. Sp), and trabecular number (Tb. N) of the mandibular bone lingual side were measured with microfocus X-ray images as healing index. In the sham group, bone exposure was not observed; BV/ TV 2-10 weeks after tooth extraction decreased from 54.04% to 12.30%; Tb.N decreased from 3.02/mm to 0.83/mm; Tb. Sp increased from 75.10μm to 285.31μm; and bone remodeling on cancellous bone increased at 6 weeks. The results in the sham group at post-extraction 6 weeks, serving as control, were compared with those in the BPdh group. In the BPdh group, bone was temporarily visible (BRONJ Stage 1) in the 0-3 week groups. Tb.N and BV/ TV in all of the 0-6 week groups were significantly higher than those in the control group; these values were significantly lower in the 6 week group than in the 0 week group. Tb. Sp was significantly higher in the 6 week group than in the 0 week group, but the value was significantly lower in both groups than in the control group. BP administration resulted in changes in BV/ TV, Tb. N, and Tb. Sp and a delay in the healing process at the extraction site. A possible mechanism might be as follows:(1) BP accumulates in the jaws and is incorporated into osteoclasts; (2) after apoptosis of osteoclasts, BP may reattach to the surface of new trabecular bone in the extraction wound even during BPdh. The cancellous bone in the 6-week BPdh group was closer to that in the control group than that in the 0 week BPdh group. Healing following tooth extraction in patients who receive intravenous BP therapy may be promoted by BPdh.
ISSN:0021-5163
2186-1579
DOI:10.5794/jjoms.60.596